Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/1999
03/24/1999CN1211444A Chinese medicinal powder preparation for treating hepatocirrhosis
03/24/1999CN1211422A Prescription for treating hepatitis and tuberculosis
03/24/1999CN1042633C Alkoxy alkyl carbamates from imidazo (1,2-a) pyridines
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886143 Reagent including at least nine hexose residues connected in iteratively branched configuration, functional moiety capable of reacting with binding moiety, target moiety or active agent
03/23/1999US5886054 Administering to a patient effective doses of scleroglucan and xanthane gum, in combination with electrolyte and preservative; saliva or tears substitute
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5886004 Tetrahydrobetacarboline compounds
03/23/1999US5886002 Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/23/1999US5885548 Diethylenetriaminepentaacetic acid derivatives, their complexes and complex salts, that contain an element of atomic numbers 20-32, 39-51 for use as contrast media and antidotes
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2052713C Delivery of agents
03/23/1999CA2025858C Antihepatopathic composition
03/23/1999CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012930A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999WO1999012926A1 Tetrahydro gamma-carbolines
03/18/1999WO1999012925A1 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND MEDICINAL COMPOSITION CONTAINING THE SAME
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012544A1 Intranasal formulation containing scopolamine and method of treating motion sickness
03/18/1999WO1999012542A1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
03/18/1999WO1999012541A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
03/18/1999WO1999012538A1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999CA2304262A1 5,11-dihydrodibenzo[b,e][i,4]oxazepine derivatives and pharmaceutical composition containing the same
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303152A1 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors
03/18/1999CA2302752A1 Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
03/18/1999CA2302470A1 Synthetic divalent slex containing polylactosamines and methods for use
03/18/1999CA2301807A1 Tetrahydro gamma-carbolines
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
03/17/1999EP0902013A1 Novel amidine derivatives, their preparation and their use as medicaments with LTB-4 antagonistic effect
03/17/1999EP0901483A2 Benzofurans and benzopyrans as chronobiological agents
03/17/1999EP0901474A1 Aryl pyrimidine derivatives
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0901371A1 Alteration of microbial populations in the gastrointestinal tract
03/17/1999EP0799231B1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
03/17/1999EP0728148B1 Improved immunogenic compositions against human gastrin 17
03/17/1999EP0688226B1 Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies of the oral cavity
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1211194A Implantable acrylamide copolymer hydrogel for therapeutic uses
03/17/1999CN1211190A Natural tea for taking off the effects of drink and process for production thereof
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211188A Urogenital and intestinal compositions
03/17/1999CN1211185A Sulfate conjugates of ursodeoxychloric acid, and their beneficial use in inflammatory disorders and other applications
03/17/1999CN1211166A Liquid oral compositions comprising a calcium compound and an acidulant
03/16/1999US5883293 Conformationally constrained backbone cyclized peptide analogs
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5882656 Useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, paget's disease, malignant hypercalcemia, and
03/16/1999CA2244232A1 Novel def
03/16/1999CA2167570C Flavanolignan preparations with improved liberation and resorbability
03/16/1999CA2167198C Benzylaminoquinuclidines
03/16/1999CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2150709C Pyrazolopyrimidines
03/16/1999CA2073226C Pyrazolopyrimidinone antianginal agents
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/16/1999CA1340444C Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011637A1 Protease inhibitors
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011278A1 Robinia pseudoacacia lectin and its uses
03/11/1999WO1999011265A1 Transdermal therapeutic system containing the active substance scopolamine base
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1998056360A3 Film-coated tablet for improved upper gastrointestinal tract safety
03/11/1999WO1998055126A3 Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999DE19738643A1 Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase Transdermal therapeutic system with the active ingredient scopolamine
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302361A1 Protease inhibitors
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2301848A1 Robinia pseudoacacia lectin and its uses
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage